Dr. Padmaja Lokireddy is a distinguished hematologist and hemato-oncologist based in Hyderabad, Telangana, with an impressive 18+ years of experience in her field. She specializes in diagnosing and treating blood disorders, aiming to deliver individualized and evidence-based treatments in healthcare. Dr. Lokireddy is credentialed with MRCP and FRCPath in Hematology, reflecting her advanced training and international qualifications in internal medicine and hematology.
From her specialty training in the UK and India, Dr. Lokireddy is adept at communicating with a diverse patient population, ensuring that all patients feel comfortable and informed. Dr. Lokireddy has held leadership roles in academics and conferences on hematology, earning numerous honors globally. Notably, she holds the distinction of being recognized among the top UK physicians for her expertise. She is committed to advancing research and clinical practice in hematology and has published extensively in national and international journals, making her a trusted authority for patients seeking specialized blood disorder and hematologic cancer care.
Dr. Padmaja Lokireddy brings over 18 years of clinical experience spanning both the UK's National Health Service and leading hospitals in India. She has served as a Consultant Haematologist and Hemato-Oncologist at Apollo Health City, Jubilee Hills, Hyderabad & Consultant Haematologist at Ipswich Hospital, Ipswich, UK (part of Cambridge Cancer Network). Her career encompasses extensive work in both adult and pediatric hematologic conditions, clinical research, and academic contributions.
Dr. Lokireddy has actively contributed to hematology research, with publications addressing platelet dysfunction, effects of red blood cell transfusion in sickle cell disease (GTS Published in BMJ), and presentations at prestigious international conferences including the European Hematology Association, American Society of Hematology, and the Annual Blood Transfusion Therapeutics Conference. Her work spans topics in coagulation disorders, transfusion medicine, and hematologic malignancies.
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.
